相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
Zachary Quinn et al.
BIOACTIVE MATERIALS (2021)
Tumor-derived exosomes in the regulation of macrophage polarization
Mirza S. Baig et al.
INFLAMMATION RESEARCH (2020)
The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass
Quentin Deveuve et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
Xiaodong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
Jiyoon Bu et al.
NANO LETTERS (2020)
PD-L1 degradation pathway and immunotherapy for cancer
Qian Gou et al.
CELL DEATH & DISEASE (2020)
Factors influencing the measurement of the secretion rate of extracellular vesicles
Yi Wen et al.
ANALYST (2020)
Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs
Li Qiao et al.
THERANOSTICS (2020)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Pooled analysis of phase I dose-escalation and dose cohort expansion studies of IMP4297, a novel PARP inhibitor, in Chinese and Australian patients with advanced solid tumors.
Junning Cao et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21
Dae-Seok Kim et al.
MOLECULAR CELL (2019)
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
Flavia Ferrantelli et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy
Xia Li et al.
APL BIOENGINEERING (2019)
Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env+ tissues
Xue Zou et al.
THERANOSTICS (2019)
Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
Yi Yang et al.
CELL RESEARCH (2018)
High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles
Andrea Longatti et al.
NANOSCALE (2018)
Extracellular Vesicles: Packages Sent With Complement
Ebru Karasu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy
Saidulu Mattapally et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Sophia G. Antimisiaris et al.
PHARMACEUTICS (2018)
Generation and testing of clinical-grade exosomes for pancreatic cancer
Mayela Mendt et al.
JCI INSIGHT (2018)
Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy
Xiaosheng Wu et al.
HELIYON (2018)
Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery
Yuan Wan et al.
CANCER RESEARCH (2018)
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer
Jason. P. W. Carey et al.
CANCER RESEARCH (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis
Tomohiro F. Nishijima et al.
ONCOLOGIST (2017)
Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes
Yuan Wan et al.
NATURE BIOMEDICAL ENGINEERING (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
Cutaneous adverse effects of the immune checkpoint inhibitors
Lindsey K. Collins et al.
CURRENT PROBLEMS IN CANCER (2017)
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
Karolina N. Dziadkowiec et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2016)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha et al.
ACTA PHARMACEUTICA SINICA B (2016)
Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs
Makon-Sebastien Njock et al.
BLOOD (2015)
PD-1/PD-L1 inhibitors
Joel Sunshine et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
Roy L. Maute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
Charles P. Lai et al.
NATURE COMMUNICATIONS (2015)
Synthesis of novel galactose functionalized gold nanoparticles and its radiosensitizing mechanism
Chuan-dong Zhu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Glucose metabolism regulatesT cell activation, differentiation, and functions
Clovis S. Palmer et al.
FRONTIERS IN IMMUNOLOGY (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Cancer exosomes and NKG2D receptor-ligand interactions: Impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance
Lucia Mincheva-Nilsson et al.
SEMINARS IN CANCER BIOLOGY (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms
Mikayel Mkrtichyan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface
Irina V. Balyasnikova et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2010)
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
Hazem Ghebeh et al.
BREAST CANCER RESEARCH (2010)
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
Takeshi Azuma et al.
BLOOD (2008)
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
BK Matuszewski et al.
ANALYTICAL CHEMISTRY (2003)
Production and characterization of clinical grade exosomes derived from dendritic cells
HG Lamparski et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Exosomes:: Composition, biogenesis and function
C Théry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9
I Farkas et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
分享论文
